Author Year Country | Study design | method of Dietary assessment | Population (Health status, N, sex, mean age) | Outcomes | Results | Adjusted variables | Quality score |
---|---|---|---|---|---|---|---|
Huang J 2024 USA [24] | cross-sectional | 24 h-Recall | General population N = 2108 M = 1044 F = 1064 Mean age: 53.9 | 1. Risk of low-eGFR 2. Correlation with eGFR | 1. Highest vs. lowest adherence: OR = 2.070; 95%CI, 1.12, 3.82 2. Significant negative correlation between DII and eGFR. | Gender, age, race, education level, poverty index, hypertension, diabetes, smoking, and drinking. | 6/9 |
Guo M 2024 China [26] | cross-sectional | 24 h-Recall | Middle-aged and elderly populations N = 23,175 M=- F=- Mean age: 60 | 1. Risk of CKD 2. Risk of low-eGFR | 1. Highest vs. lowest adherence: OR = 1.08; 95%CI, 1.05, 1.10 2. Highest vs. lowest adherence: OR = 1.16; 95%CI, 1.13, 1.19 | Race, age, sex, education level, smoking status, PIR, BMI, albumin, glucose, glycosylated hemoglobin, ALT, AST, serum iron, potassium, cholesterol, triglycerides, BUN, uric acid, hypertension, coronary heart disease, congestive heart failure, stroke, arthritis, cancer, and diabetes. | 7/9 |
Guo C 2023 China [27] | cross-sectional | 24 h-Recall | Patients with type-2 diabetes mellitus N = 7974 M = 4131 F = 3843 Mean age: 59.5 | Risk of CKD | Highest vs. lowest adherence: OR = 1.67; 95%CI, 1.29, 2.17 | Age, sex, ethnicity, smoking, drinking, body mass index (BMI), triglyceride (TG), total cholesterol (TC), metabolic equivalents (METs), energy intake, hypoglycemic medications, hypertension, and cardiovascular disease (CVD). | 7/9 |
Moludi 2022 Iran [34] | cross-sectional | FFQ | General population N = 9824 M = 4610 F = 5214 Age: 35–65 | Risk of CKD | Highest vs. lowest adherence: OR = 1.92; 95%CI, 1.52–2.42 | Age, gender, smoking status, BMI, place, education level, and physical activity, HEI, kidney stone, diabetes, and high blood pressure. | 5/9 |
Lin 2021 China [35] | cross-sectional | FFQ | Women with diabetes, prediabetes and normal glucose N = 2644 F = 2644 Mean age: 55.3 | 1. Risk of low-eGFR 2. Correlation with eGFR | 1a. Highest vs. lowest adherence in diabetes: OR = 15.519; 95%CI, 1.373, 175.377 1b. Highest vs. lowest adherence in prediabetes: OR = 2.413; 95%CI, 0.688, 8.461 1c. Highest vs. lowest adherence in normal blood glucose participants: OR = 1.439; 95%CI, 0.250, 8.300 2. Significant negative correlation between DII and eGFR in patients with diabetes. But no significant correlation in patients with pre-diabetes and normal glucose. | Age, BMI, current smoking, alcohol intake and exercise, systolic BP, diastolic BP, glucose, LD, HDL, triglyceride, cholesterol | 7/9 |
Mazidi 2018 USA [16] | cross-sectional | 24 h-Recall | General population N = 21,649 M= - F= - Age: ≥18 | 1. Risk of CKD 2. Risk of low-eGFR 3. Association with eGFR 4. Association with Cr 5. Association with uric acid | 1. Highest vs. lowest adherence: OR = 1·23; 95%CI, 1.10, 1.35 2. Highest vs. lowest adherence: OR = 1·29; 95%CI, 1·03, 1·62 3. Significant decrease in mean eGFR across increasing E-DII quartiles. 4. Nonsignificant increase in mean Cr across increasing E-DII quartiles. 5. Significant decrease in mean uric acid across increasing E-DII quartiles. | Blood glucose, blood pressure, BMI, diabetes, hypertension status | 6/9 |
Wang 2022 USA [36] | cross-sectional | 24 h-Recall | Diabetes N = 4264 M = 2241 F = 2023 Age: >20 | 1. Risk of low-eGFR 2. Risk of DKD | 1. Highest vs. lowest adherence: OR = 1.57; 95%CI, 1.10, 2.26 2- Highest vs. lowest adherence: OR = 1.64; 95%CI, 1.24, 2.17 | Age, sex, race, educational level, marriage status, family poverty income ratio, smoking status, drinking status, physical activity level, hypertension and BMI. | 6/9 |
Qu 2024 USA [37] | cross-sectional | 24-hour dietary recall | General population N = 18,070 M = 8906 F = 9164 Age: ≥ 20 | 1. Risk of CKD 2. Risk of low-eGFR | 1. Highest vs. lowest adherence: OR = 1.24; 95%CI, 1.11, 2.64 2. Highest vs. lowest adherence: OR = 1.71; 95%CI, 0.95, 1.63 | Age, sex, race, education level, marital status, PIR, BMI, smoking status, physical activity, diabetes, hypertension and energy | 6/9 |
Zeng 2023 USA [38] | cross-sectional | 24-hour dietary recall | Adults Aged 50 Years and Older N = 12,090 M= - F= - Age: ≥ 50 | Risk of low-eGFR | Highest vs. reference adherence: OR = 2.08; 95%CI, 1.30–2.86 | Age, sex, body mass index, race/ethnicity, education, ratio of family income to poverty, smoking, physical activity, hypertension, diabetes, and daily intakes of total plain water, total energy, and sodium. | 7/9 |
Xu Z 2024 USA [39] | cross-sectional | 24 h-Recall | CKD patients N = 2488 M: 1183 F: 1304 Mean age: 67.11 ± 15.56 | 1. Risk of higher CKD Stages 2. Correlation with eGFR | 1- Highest vs. reference adherence: OR = 2.29; 95%CI, 1.42, 3.71 2. Significant negative correlation between DII and eGFR. | Age, gender, race, education level, poverty income ratio (PIR), marital status, body mass index (BMI), metabolic equivalent (MET) score, drinking, smoking, history of hypertension, history of diabetes, cotinine, systolic blood pressure, diastolic blood pressure, total triglycerides, and total cholesterol | 7/9 |
Vahid 2023 Luxemburg [25] | cross-sectional | FFQ | General population N = 1404 M = 654 F = 750 Age: 25–79 | 1. Correlation with eGFR 2. Correlation with uric acid | 1. No Significant correlation between DII and eGFR. 2. No Significant correlation between DII and uric acid. | Age, gender, birth country, marital status, education, job, income, IPAQ scoring, current smoking | 6/9 |
Bondonno 2020 Australia [52] | Cohort (10 years)/ cross-sectional | FFQ | Older women N = 2644 F = 2644 Mean age: 55.3 | Correlation with eGFR | Significant negative correlation between DII and eGFR both at the baseline and after 10 years. | Age, energy intake, treatment code (calcium or placebo), BMI, smoking status, physical activity, alcohol intake, diabetes status, use of antihypertensive medication, prevalent ASVD, statin use, and use of NSAIDs for joint pain | 7/9 |
Tajik 2019 Iran [40] | cross-sectional | FFQ | Elderly population N = 221 M = 65 F = 161 Mean age: 67 ± 5.7 | 1. Correlation with eGFR 2. Association with Creatinine | 1. No Significant correlation between DII and eGFR. 2. No significant association between mean Cr and DII. | Energy intake, age, sex, BMI, smoking status, physical activity, hypertension, diabetes, use of lipid-lowering medication, angiotensin II receptor blockers (ARB) and angiotensin-converting enzyme inhibitor (ACEI), steroidal and non- steroidal anti-inflammatory medications. | 6/9 |
Xu H 2015 Sweden [41] | cross-sectional | 7-d food records | Elderly population N = 1942 M = 1520 F = 422 Age: 70–71 | Correlation with eGFR | Significant negative correlation between DII and eGFR. | Energy intake, age, sex, smoking status, physical activity, hypertension, diabetes, use of lipid-lowering medication, and whether the participants were from the Uppsala Longitudinal Study of Adult Men or the Prospective Investigation of Vasculature in Uppsala Seniors, BMI, CRP | 7/9 |
Rouhani 2018 Iran [42] | cross-sectional | FFQ | CKD patients N = 221 M= - F= - Mean age: - | 1. Risk of higher CKD Stages 2. Association with eGFR 3. Association with Cr 4. Association with BUN | 1. Highest vs. lowest adherence: OR = 2.12; 95%CI, 1.05, 4.26 2. No significant association between mean eGFR and DII. 3. No significant association between mean Cr and DII. 4. No significant association between mean BUN and DII. | Socioeconomic status, height and weight, systolic and diastolic blood pressure | 5/9 |
Alkerwi 2015 Luxembourg [22] | cross-sectional | SQ-FFQ | General population N = 1352 M= - F= - Age: 18–69 | 1. Correlation with Cr 2. Correlation with uric acid | 1. No Significant correlation between DII and Cr 2. No Significant correlation between DII and uric acid. | Age (continuous), sex, education level (primary, secondary or tertiary), smoking status (smoker or non-smoker), physical activity in metabolic equivalents-h/week | 5/9 |
Farhangi 2018 Iran [23] | cross-sectional | SQ-FFQ | Candidates of CABG surgery N = 454 M = 332 F = 122 Age: 35–80 | 1. Correlation with Cr 2.Correlation with BUN | 1. Significant positive correlation between DII and Cr in male patients, but not in female patients. 2. Significant positive correlation between DII and BUN in male patients, but not in female patients. | Age, gender, BMI, educational attainment and presence of diabetes and myocardial infarction | 5/9 |
Bavi Behbahani 2022 Iran [43] | cross-sectional | FFQ | Atherosclerosis patients N = 320 M = 171 F = 149 Age: ≥ 20 | 1. Correlation with Cr 2. Correlation with BUN | 1. No Significant correlation between DII and Cr. 2. No Significant correlation between DII and BUN. | Age, sex, energy intake, physical activity, race, BMI, WC, marital status, and education. | 5/9 |
Rodgers 2024 Spain [50] | Case-control | SQ-FFQ | Cases: kidney stone formers. Controls: individuals with no history of kidney stone. N = 160 (Cases:97, Controls:63) M = 111 F = 49 Mean Age: 47 | 1. Correlation with Cr 2. Correlation with uric acid | 1. No Significant correlation between DII and Cr. 2. No Significant correlation between DII and uric acid. | Sex, age and for the statistically significant predictors of the univariate analyses | 6/9 |
Carrasco-MarÃn 2024 UK [44] | cross-sectional | 24 h dietary recall | Healthy adults N = 66,978 M = 30,852 F = 36,126 Age: 37–73 | 1. Correlation with Cr 2. Correlation with uric acid | 1. Significant negative correlation between DII and Cr. 2. No Significant correlation between DII and uric acid. | Age, sex, deprivation, smoking, alcohol consumption, physical activity, and BMI. | 6/9 |
Kizil 2016 Turkey [45] | cross-sectional | 3-day dietary recall | Hemodialysis patients N = 150 M = 68 F = 82 Mean age: 57.5 ± 12.4 | Association with Cr | No significant association between mean Cr and DII. | Gender, education level, and marital status. | 3/9 |
Lu 2024 USA [46] | cross-sectional | 24 h-Recall | patients with hypertension N = 17,294 M = 8642 F = 8652 Mean age = 59.78 ± 0.18 | Risk of CKD | Highest vs. lowest adherence: OR = 1.38; 95%CI, 1.15,1.65 | Age, gender, race, education, family income, smoking status, alcohol intake, and diabetes. | 6/9 |
Rivera-Paredez 2024 Mexico [47] | cross-sectional | SQ-FFQ | patients with hypertension N = 2098 M = 32.4% F = 67.6% Mean age = 47 | Correlation with eGFR | Significant negative correlation between DII and eGFR. | Age, smoking, drinking, physical activity, hypertension, BMI, glucose, lipids, and blood pressure | 6/9 |
Rui 2024 USA [48] | cross-sectional | 24 h-Recall | patients with DM N = 2712 M = 32.4% F = 67.6% Mean age = 47 | Risk of DKD | Highest vs. lowest adherence: OR = 0.9; 95%CI, -0.6, 2.4 | Age, gender, race, education level, PIR, BMI, waistline, total energy intake, HbA1c, FPG, Ualb, Ucr, BUN, SUA, TC, TG, HDL, LDL, ALT, AST, Hypertension, MetS, taking prescription for hypertension, taking prescription for to lower blood sugar, Taking prescription for cholesterol | 7/9 |
Huang Y 2024 USA [53] | cross-sectional | 24 h-Recall | General population N = 25,167 M = 48.3% F = 51.7% Mean age = 49.2 | Risk of CKD | Highest vs. lowest adherence: OR = 1.56; 95%CI, 1.34, 1.82 | Age, gender, race/ethnicity, body mass index, smoking status, poverty status, education levels, alcohol consumption, leisure time physical activity, history of diabetes. | 6/9 |
Guo L 2024 USA [49] | cross-sectional | 24 h-Recall | General population N = 40,388 Without CKD: M = 50.42% F = 49.58% Mean age = 44.99 With CKD: M = 43.20% F = 56.80% Mean age = 60.84 | Risk of CKD | Highest vs. lowest adherence: OR = 1.24; 95%CI, 1.12, 1.37 | Sex, age group, race, education, marital status, BMI, smoking, and drinking status, hypertension, and diabetes. | 6/9 |
Li 2024 USA [51] | Cohort (19 years) | 24 h-Recall | General population N = 23,099 M= - F= - Age = ≥ 18 | Risk of CKD | Highest vs. lowest adherence: HR = 1.36; 95%CI, 1.23–1.51 | Systolic blood pressure (SBP), total cholesterol (TC), age, education, BMI, serum creatinine, smoking habit, sex, and race. | 6/9 |